Amiloxate

Amiloxate

SCHEMBL128150

CCCCCC(CC)OC(=O)/C=C/c1ccccc1OC.COc1ccc(C=CC(=O)OCCC(C)C)cc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.59
LMNA P02545 2/20 0.59
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAOB P27338 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
APP P05067 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TTR P02766 1/20 0.39
GAA P10253 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
AKR1B10 O60218 1/20 0.39
AKR1B1 P15121 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amiloxate SCHEMBL128151 0.91 TDP1 (0.71) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
Octinoxate SCHEMBL420736 0.87 TDP1 (0.68) TDP1LMNAKDM4EALDH1A1HPGD
Amiloxate SCHEMBL19899316 0.86 LMNA (0.71) TDP1LMNAKDM4EALDH1A1HPGD
SCHEMBL7606022 0.85 TDP1 (0.60) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
Octocrylene SCHEMBL5160335 0.85 ALDH1A1 (0.51) TDP1LMNAKDM4EALDH1A1HPGD
SCHEMBL14562456 0.84 NFE2L2 (0.52) TDP1LMNAKDM4EALDH1A1HPGD
SCHEMBL62156 0.84 NFE2L2 (0.52) TDP1LMNAKDM4EALDH1A1HPGD
SCHEMBL31710835 0.84 NFE2L2 (0.52) TDP1LMNAKDM4EALDH1A1HPGD
SCHEMBL14698300 0.82 TDP1 (0.62) TDP1LMNASMN1; SMN2MAOBTAS1R3
SCHEMBL35994 0.82 TDP1 (0.62) TDP1LMNASMN1; SMN2MAOBTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1965758-B1 COMPOSITIONS CONTAINING PROTEINS FOR THE TRANSFER/RECYCLING OF STRUCTURALLY MODIFIED LIPIDS, AND THE APPLICATIONS THEREOF MERZ PHARMA GMBH & CO KGAA (DE) 2012-03-07 EP disclosed